Effect of Noninvasive Brain Stimulation on Hypokinetic Dysarthria in Parkinson's Disease
1 other identifier
interventional
39
1 country
1
Brief Summary
Hypokinetic dysarthria (HD) is common in Parkinson's disease (PD) patients and responds only partially to pharmacotherapy and surgery. The investigators will explore long-term effects of repetitive transcranial magnetic stimulation (rTMS) applied over right superior temporal gyrus, brain area known to be engaged in the feedback control of voiced speech. The project results will allow for the identification of potential therapeutic effects of rTMS as a tool that could contribute to the speech therapy of HD in PD patients. The results will also enhance our understanding of brain mechanisms underlying specific long-term effects of rTMS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Jul 2019
Shorter than P25 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
December 9, 2019
CompletedFirst Posted
Study publicly available on registry
December 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2020
CompletedSeptember 2, 2020
September 1, 2020
7 months
December 9, 2019
September 1, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in score of the 3F Test (the unabbreviated title- "the 3F Test Dysarthric Profile")
The 3F Test Dysarthric Profile enables clinicians to characterize a wide range of signs and symptoms of dysarthria. The minimum value of this scale is 0 (anarthria), the maximum value is 90 (no disorder). Higher scores of this scale mean better outcome. This test will be administrated by speech pathologist.
On the beginning of the study, after completion of two weeks stimulation, 4,8 and 12 weeks after completion of stimulation sessions.
Secondary Outcomes (1)
Resting state
On the beginning of the study, after completion of two weeks stimulation, 4,8 and 12 weeks after completion of stimulation sessions.
Study Arms (2)
PD patients with real rTMS
ACTIVE COMPARATORPatients will receive real rTMS in a two weeks long sessions (10 sessions).
PD patients with sham rTMS
SHAM COMPARATORPatients will receive sham rTMS in a two weeks long sessions (10 sessions).
Interventions
Transcranial magnetic stimulation- sham figure-eight coil will be used for stimulation. This sham coil will generate only clicking noise and will not generate any magnetic field.
Transcranial magnetic stimulation- figure-eight coil will be used for stimulation. 1 Hz stimulation, 100% of Resting Motor Threshold will be used.
Eligibility Criteria
You may qualify if:
- patients with clinically established PD (Postuma et al. 2016)
You may not qualify if:
- psychiatric disorders, including major depression, hallucinations
- any MRI-incompatible metal in the body
- epilepsy
- lack of cooperation
- presence of dementia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Central European Institute of Technology
Brno, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2019
First Posted
December 18, 2019
Study Start
July 1, 2019
Primary Completion
January 30, 2020
Study Completion
January 30, 2020
Last Updated
September 2, 2020
Record last verified: 2020-09